|
||
By Rory O’Neill, Hazards Magazine editor A recent Oxford University study concluding that night shift work should no longer be classified as a cause of breast cancer was based on bad science, top researchers warn. The large scale meta-analysis using data from 1.4 million women, published online on October 6th, 2016 in the Journal . . . → Read More: Cancer All-Clear For Night Work Based On Bad Science 
“Cancer Cells Spread Way Earlier Than Thought,” Sharon Begley, STAT. A highly readable article by journalist Sharon Begley in STAT discusses new research demonstrating that cancer cells are able to spread from a tumor much earlier than once believed. What’s more, these cells are more adept at forming potentially lethal metastases at distant sites (such . . . → Read More: Cancer Cells Spread Way Earlier Than Thought 
Death is certain. Time of death is not. But in Hospital Land USA, the other S&M (Science and Medicine) as Wendy Simonds calls it, death is a failure, something to be suspended and avoided at whatever cost. And there is no safe word. The surreal ordinariness of it all – from appointments and forms to . . . → Read More: Book Review: Hospital Land USA 
Read in PDF » The U.S. Food and Drug Administration (FDA) has increasingly used an accelerated pathway to speed up the conditional approval of drugs that treat serious medical conditions and fill an unmet need. Provisional approval hinges upon two major factors: (1) surrogate endpoints (i.e., markers of effectiveness such as a decrease . . . → Read More: Research Brief: Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints
“Congress Shouldn’t Pass FDA Reform Bills Without Addressing Patient Safety and Drug Prices,” Diana Zuckerman, The Health Care Blog. A major proposed law that alters the way the Food and Drug Administration (FDA) approves drugs and medical devices has been wending its way through Congress since 2014. The Cures bill and Senate legislation seek . . . → Read More: Congress Shouldn’t Pass FDA Reform Bills Without Addressing Patient Safety and Drug Prices 
The Lown Institute’s Right Care Alliance is building a grassroots social movement to fix healthcare by reaching out to the public and healthcare practitioners. The mission is basic and profound: Profit-driven overuse, under-use, and misuse of medical tests and treatments have subverted the work of health care providers. A much better health care system is . . . → Read More: Update on Lown Institute’s Right Care Action Week 
“In a commercial social movement, activists work cooperatively with industry rather than contentiously against it; they employ market mechanisms like cause marketing and corporate-sponsored runs rather than defiant protests or marches. Necessarily conservative… it is a continuation of rather than a sharp break from the past.” — Hiding Politics in Plain Sight: Cause Marketing, Corporate . . . → Read More: Book Review: Hiding Politics in Plain Sight 
Each decade, breast cancer incidence rises and the environments of our homes, workplaces, and ecosystems become more polluted beyond anyone’s personal control. Is this just a coincidence? No. Yet, there is little mainstream attention to this fact. The feel-good breast cancer awareness narrative highlights product placements, optimistic survivor stories, pinked entertainment, and a watered . . . → Read More: From Pink to Prevention
“Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer,” Mary Chris Jaklevic, Health News Review. Genetic testing for breast and ovarian cancer risk is cheaper and easier than ever. But just because a test is available doesn’t mean everyone should get it. That message didn’t come through in a recent series of . . . → Read More: Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer
“A banner week for CDA (Celebrity Disease Awareness),” Alan Cassels, Health News Review. Celebrity disease awareness (or pushing of disease-mongered conditions) is not going away soon. But maybe it could be tied to the goal of informing consumers instead of misleading them or promoting personal financial incentives. Here are a few celebs, for better or . . . → Read More: A banner week for CDA (Celebrity Disease Awareness) |
||
| Copyright © 2025 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||